NRx Pharmaceuticals Inc.
NRXP | NASDAQ
$3.27
-$0.02 (-0.61%)
Sep 22, 2026, 11:01 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -16.52M | -1.43M | 360K | -5.89M | -17.58M | -5.51M | -9.08M | -1.62M | -7.9M | -6.53M | -4.33M | -6.06M | -8.72M | -11.04M | -10.24M | -9.08M | -6.98M | -13.45M | -30.79M | -20.77M | -117.61K | -25.49M |
Depreciation & Amortization | 173K | 165K | 100K | 41K | -1K | 1K | 1K | 2K | 1K | 1K | 1K | 2K | 1K | 1K | 1K | 1K | 1K | 1K | 395 | 638 | 967 | n/a |
Stock-Based Compensation | 139K | 151K | 81K | 68K | 67K | 12K | 43K | 104K | 97K | 242K | -1.2M | 351K | 544K | 695K | 766K | 541K | 987K | 1.33M | 1.57M | 1.56M | 4.28M | 372K |
Other Working Capital | -2.14M | 250K | 1.31M | -34K | 163K | -178K | 548K | -388K | -14K | 196K | 1.42M | -713K | 1.01M | 796K | 762K | 3.15M | -4.97M | 3.37M | 935.48K | 8.95M | -2.62M | -1.21M |
Other Non-Cash Items | 10.78M | -3.51M | -5.61M | 2.39M | 14M | 2.02M | 7.02M | -1.14M | 2.19M | 327K | -80K | 359K | 924K | 1.76M | 486K | 37K | -2.6M | -2.26M | 18.88M | 8.34M | -11.5M | 21.25M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 260.24K | n/a | n/a |
Change in Working Capital | -3.45M | 331K | 1.36M | 567K | -516K | n/a | 548K | 352K | 2.1M | 2.29M | 2.42M | 812K | -564K | 2.49M | 670K | 2.24M | -6.2M | 3.99M | -937.76K | -1.4M | -2.62M | 852K |
Operating Cash Flow | -8.88M | -4.3M | -3.71M | -2.89M | -4.03M | -3.48M | -1.46M | -2.31M | -3.51M | -3.67M | -3.19M | -4.56M | -7.81M | -6.09M | -8.32M | -6.27M | -14.79M | -10.38M | -11.28M | -12.01M | -14.23M | -3.02M |
Capital Expenditures | -897K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | -2K | 2K | -4K | 1K | -5K | -3K | -3K | -388 | -3.83K | -2.78K | n/a |
Cash Acquisitions | n/a | n/a | 183K | -2.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | 213K | -213K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -432K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -684K | -213K | -249K | -2.56M | n/a | n/a | n/a | n/a | n/a | n/a | 1K | -2K | 2K | -4K | 1K | -5K | -3K | -3K | -388 | -3.83K | -2.78K | n/a |
Debt Repayment | 412K | n/a | 196K | -225K | 378K | 4.68M | 3.32M | -533K | 942K | -2.16M | -1.12M | -2.67M | 696K | n/a | 10.02M | n/a | -518K | n/a | 474 | -176.47K | -1.28M | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 2.74M | -1K | n/a | -350K | n/a | 2.37M | n/a | n/a | n/a | n/a | n/a | n/a | 10K | n/a | -518K | n/a | -117 | n/a | 11.05M | 7.5M |
Financial Cash Flow | 29.53M | 3.42M | 4.58M | 9.73M | 1.39M | 7.59M | 1.26M | 2.05M | 4.08M | 395K | -1.12M | -1.5M | 6.27M | 2.55M | 10.12M | -28K | -860K | 22.98M | 1.24K | 37.52M | 25.76M | 14.43M |
Net Cash Flow | 19.97M | -1.08M | 613K | 4.27M | -2.64M | 4.11M | -203K | -252K | 579K | -3.28M | -4.31M | -6.07M | -1.54M | -3.55M | 1.81M | -6.3M | -15.65M | 12.6M | -11.28M | 25.5M | 13.39M | 11.41M |
Free Cash Flow | -9.77M | -4.3M | -3.71M | -2.89M | -4.03M | -3.48M | -1.46M | -2.31M | -3.51M | -3.67M | -3.19M | -4.57M | -7.81M | -6.09M | -8.32M | -6.27M | -14.79M | -10.38M | -11.28M | -12.02M | -14.23M | -3.02M |
Adj. Free Cash Flow | -9.91M | -4.45M | -3.79M | -2.96M | -4.1M | -3.49M | -1.51M | -2.41M | -3.6M | -3.91M | -1.99M | -4.92M | -8.35M | -6.79M | -9.08M | -6.81M | -15.78M | -11.72M | -12.85M | -13.58M | -18.52M | -3.39M |
Maintenance CapEx | -173K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -2K | -1K | -1K | -1K | -1K | -1K | -1K | -388 | -638 | -967 | n/a |
Growth CapEx | -724K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | n/a | 3K | -3K | 2K | -4K | -2K | -2K | n/a | -3.19K | -1.81K | n/a |
Owner Earnings | -9.05M | -4.3M | -3.71M | -2.89M | -4.03M | -3.48M | -1.46M | -2.31M | -3.51M | -3.67M | -3.19M | -4.57M | -7.81M | -6.09M | -8.32M | -6.27M | -14.79M | -10.38M | -11.28M | -12.02M | -14.23M | -3.02M |
Add to Watchlist
Select watchlists to add or remove NRXP